Cleo Diagnostics (ASX:COV) Accumulated Depreciation : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Cleo Diagnostics's quarterly accumulated depreciation increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$-0.00 Mil) but then stayed the same from Jun. 2023 (A$-0.00 Mil) to Dec. 2023 (A$0.00 Mil).

Cleo Diagnostics's annual accumulated depreciation stayed the same from . 20 (A$0.00 Mil) to . 20 (A$0.00 Mil) and stayed the same from . 20 (A$0.00 Mil) to Jun. 2023 (A$-0.00 Mil).

Cleo Diagnostics Accumulated Depreciation Historical Data

The historical data trend for Cleo Diagnostics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Accumulated Depreciation Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Accumulated Depreciation

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Accumulated Depreciation	-	-	-

Cleo Diagnostics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Cleo Diagnostics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines